Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia.
(1987) European Journal of Haematology — Vol. 39, n° 3, p. 228-232 (1987)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- 2 patients with myelofibrosis and myeloid metaplasia had symptomatic splenomegaly and were treated with interferon alpha-2c (IFN alpha-2c). The splenic pain and pressure symptoms disappeared, accompanied by a decrease in the size of the spleen. However, the peripheral blood count worsened and no improvement in the bone marrow fibrosis could be observed.
- Affiliations
Citations
Parmeggiani, L., Ferrant, A., Rodhain, J., Michaux, J.-L., & Sokal, G. (1987). Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia. European Journal of Haematology, 39(3), 228-232. https://hdl.handle.net/2078.5/78539 (Original work published 1987)